03/03/09: Duke, LabCorp Sign NCRC Pact
Burlington-based Laboratory Corporation of America and Duke University have signed an agreement to collaborate on processing of human biological samples to be stored at LabCorp's soon-to-open Biorepository at the North Carolina Research Campus in Kannapolis.
LabCorp did not disclose financial or other details when announcing the agreement. The company said only that it "focuses on the operation of the facility, as well as the management of samples deposited by Duke University, and its clients and collaborators, including samples from the MURDOCK study, which is applying modern-day technologies to identify genomic linkages across major chronic diseases and disorders."
"The combined capabilities of our organizations through the Biorepository will further our leadership in personalized medicine and will lead to new discoveries and new diagnostic tests that will benefit patient care," said David King, LabCorp CEO.
The Biorepository, which is expected to open later this year, will have the capacity to house up to 10 million samples and will offer both a high-security storage environment and on-site nucleic acid and sample preparation capabilities.
"The future of healthcare is in personalized and genomic medicine which will require an ability to store and analyze large quantities of tissue and blood samples," said Victor Dzau, M.D., chancellor for health affairs and CEO of the Duke University Health System.